Search this Site

FDA Information

Abciximab (previously known as c7E3 Fab), is manufactured by Centocor and distributed by Eli Lilly under the trade name ReoPro®.

Abciximab is an FDA approved medication for patients undergoing elective PCI with a stent, or with an acute coronary syndrome (unstable angina or non-ST elevation MI). More than 2 million patients have been treated worldwide with abciximab since its approval by the FDA in 1994.

Please visit the official site of the FDA for further information.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.